News

Strategies Aim to Optimize Hepatitis B Therapy

Publish date: July 1, 2010
PDF Download

 

Source DR. RIJCKBORST

Ninety-six weeks of pegylated interferon yielded a higher sustained response rate than did 48 weeks.

Source DR. LAMPERTICO

Pages

Recommended Reading

Inflammatory Bowel Disease Tied to Pancreatic Cancer Risk
MDedge Internal Medicine
Medication Costs Can Plummet After Bariatric Surgery
MDedge Internal Medicine
High Intake of Animal Protein Tied to IBD Risk
MDedge Internal Medicine
Genomic Profile Points to Recurrence of HCC
MDedge Internal Medicine
Ablation Benefits Remain at 5 Years in Barrett's
MDedge Internal Medicine
Hepatic Encephalopathy Diagnostic Test Effective
MDedge Internal Medicine
PPIs Can Cause 'Addiction' to Acid Suppression
MDedge Internal Medicine
Insulin Resistance May Raise Risk of Barrett's Esophagus
MDedge Internal Medicine
Support Grows for Earlier Colonoscopy in Blacks
MDedge Internal Medicine
Diminutive Polyps Not Likely to Become Cancerous
MDedge Internal Medicine